9.000
−3,23%
2026-10-19
Fundamental Analysis
22 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -343.1% | -109.2% | 1 / 3 | +82.3% | -0.35 pp | -1.60 pp | +0.3% | 4.35 | 180.39 | 163 | +82,3% | −7,3 | −183,0% | 180.39 | 42.89 | +320,6% |
| Pts | 0 | 0 | 4 | 12 | 4 | 4 | 0 | -4 | 4 | |||||||
Valuation annotation:Price: 9.000 (close price on 2026-10-19)EPS (TTM): 49,9
Financial charts
1.Revenue & growth
VND bn163Q2/26
1.Revenue & growth
VND bn163Q2/26
2.Profit & growth
VND bn-7,16Q2/26
3.Profit mix (Penman)
VND bn2,03Q2/26
4.Margins & cost structure
%9.6%Q2/26
5.Returns & cash cycle
% · days3.9%Q2/26
6.Earnings quality & cash
VND bn-135Q2/26
7.Asset structure
VND bn461Q2/26
8.Funding & debt health
VND bn · times461Q2/26
9.Revenue backlog
VND bn4,01Q2/26
10.Valuation
times · %220,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-1.580Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-7.7%
averaged over 1 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26